一个多标配方体 (JM-20) 阻止了吗啡诱导的过敏症在原始和神经病变的老鼠
Bárbara B Garrido-Suárez1, Gabino Garrido2, Addis Bellma-Menéndez3
1Centro de Investigación y Desarrollo de Medicamentos, Ave 26, No. 1605 Boyeros y Puentes Grandes, CP 10600, La Habana, Cuba; Instituto de Ciencias del Mar, Loma y 37, Nuevo Vedado, Havana, CP 10300, Cuba.
European journal of pharmacology
|September 12, 2024
概括
JM-20是一种神经保护性化合物,有效地预防了大鼠的吗啡诱导的过敏症和戒断症状. 它还减少了慢性收缩损伤模型中的神经损伤和炎症,这表明了潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 像吗啡这样的阿片类止痛药可以诱导过敏症和神经炎症.
- 慢性收缩损伤 (CCI) 模型加剧了阿片类药物引起的疼痛和神经损伤.
研究的目的:
- 为了研究神经保护性化合物JM-20对吗啡诱导的过敏症的疗效.
- 评估JM-20对机械过敏和坐骨神经组织病理学在CCI大鼠在吗啡暴露下的影响.
主要方法:
- 在注射吗啡之前,JM-20口服给雄性斯普拉格-道利大鼠.
- 使用电子压力计脚,热板和甲测试来评估疼痛行为.
- 在CCI和假模型中分析的坐骨神经组织病理学和炎症标志物 (互白素-1β,谷氨).
主要成果:
- JM-20显著抑制了吗啡诱导的过敏症和体质戒断症状.
- JM-20 降低了脊髓中白蛋白-1β,并恢复了谷氨水平.
- 在CCI大鼠中,JM-20降低了机械过敏性,减少了免疫细胞透到坐骨神经中,即使在停止服用吗啡后也是如此.
结论:
- JM-20显示出强大的抗过敏和抗炎作用.
- 该化合物减轻了与慢性吗啡使用和CCI相关的神经炎症和神经损伤.
- JM-20显示为治疗阿片类药物诱导的过敏症和相关的神经病痛的治疗药物.
相关概念视频
Analgesia and Pain Management
552
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
Opioid Analgesics: Synthetic and Semisynthetic Opioids
251
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
251
Opioid Analgesics: Morphine and Other Natural Cogeners
192
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Opioid Receptors: Overview
588
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
588
Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K


